Maravai LifeSciences
MRVI
MRVI
235 hedge funds and large institutions have $4.51B invested in Maravai LifeSciences in 2022 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 80 increasing their positions, 79 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.13% less ownership
Funds ownership: 97.44% → 97.31% (-0.13%)
16% less capital invested
Capital invested by funds: $5.36B → $4.51B (-$852M)
Holders
235
Holding in Top 10
2
Calls
$14M
Puts
$3.13M
Top Buyers
| 1 | +$37.2M | |
| 2 | +$33.5M | |
| 3 | +$32.3M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$29.4M |
| 5 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
+$25.2M |
Top Sellers
| 1 | -$110M | |
| 2 | -$59.7M | |
| 3 | -$48.4M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$35.7M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$16.5M |